Ken is currently CEO of Lightstone Singapore PTE. LTD.
Previously Ken was a senior partner and head of the European Life Sciences practice at L.E.K. Consulting LLP. Ken has been a Board of Director member of public and private life science companies in both the U.S. and Europe to include Intercept Pharmaceuticals Inc., Kailos Genetics and Orchid Biosciences.
During his academic career Ken authored more than 50 articles on the role of the cell surface in cell division."
B.S. Biology St. Joseph's University
Ph.D. Biochemistry Princeton University